- Home
- BCML vs ITOS Comparison
BCML vs ITOS Comparison
Compare BCML & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCML
- ITOS
- Stock Information
- Founded
- BCML 2004
- ITOS 2011
- Country
- BCML United States
- ITOS United States
- Employees
- BCML N/A
- ITOS N/A
- Industry
- BCML Major Banks
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BCML Finance
- ITOS Health Care
- Exchange
- BCML Nasdaq
- ITOS Nasdaq
- Market Cap
- BCML 279.0M
- ITOS 270.7M
- IPO Year
- BCML N/A
- ITOS 2020
- Fundamental
- Price
- BCML $25.02
- ITOS $7.26
- Analyst Decision
- BCML
- ITOS Strong Buy
- Analyst Count
- BCML 0
- ITOS 3
- Target Price
- BCML N/A
- ITOS $26.00
- AVG Volume (30 Days)
- BCML 18.7K
- ITOS 370.8K
- Earning Date
- BCML 04-17-2025
- ITOS 03-05-2025
- Dividend Yield
- BCML 2.40%
- ITOS N/A
- EPS Growth
- BCML N/A
- ITOS N/A
- EPS
- BCML 2.10
- ITOS N/A
- Revenue
- BCML $96,253,000.00
- ITOS $35,000,000.00
- Revenue This Year
- BCML $3.69
- ITOS N/A
- Revenue Next Year
- BCML $6.08
- ITOS $121.70
- P/E Ratio
- BCML $11.93
- ITOS N/A
- Revenue Growth
- BCML N/A
- ITOS 177.89
- 52 Week Low
- BCML $18.54
- ITOS $6.67
- 52 Week High
- BCML $30.13
- ITOS $18.75
- Technical
- Relative Strength Index (RSI)
- BCML 36.85
- ITOS 48.19
- Support Level
- BCML $24.37
- ITOS $6.73
- Resistance Level
- BCML $27.77
- ITOS $7.65
- Average True Range (ATR)
- BCML 0.67
- ITOS 0.36
- MACD
- BCML -0.25
- ITOS 0.04
- Stochastic Oscillator
- BCML 19.12
- ITOS 53.06
About BCML BayCom Corp
BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services.
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.